Home  »  Stock   »  Don’t Miss Out on this Buy-In Window for Agios P...

Don’t Miss Out on this Buy-In Window for Agios Pharmaceuticals Inc. (AGIO)

Let’s start up with the current stock price of Agios Pharmaceuticals Inc. (AGIO), which is $29.80 to be very precise. The Stock rose vividly during the last session to $32.33 after opening rate of $32.33 while the lowest price it went was recorded $29.63 before closing at $32.18.Recently in News on September 19, 2022, Agios Appoints Cecilia Jones as Chief Financial Officer. Cecilia Jones. You can read further details here

Agios Pharmaceuticals Inc. had a pretty Dodgy run when it comes to the market performance. The 1-year high price for the company’s stock is recorded $35.12 on 01/05/22, with the lowest value was $16.75 for the same time period, recorded on 06/16/22.

China Can't Stop US$0.25 Stock from Mining Ultra-Rare Metal

Here's one little-known company — trading undiscovered below 25-cents per share — that's advancing one of the largest and highest quality REE deposits in all of North America... and the Chinese can't do a damn thing about it! It's early stage... and that's excellent news for individual investors like you who have the foresight to act decisively on an emerging megatrend that's already being measured in the Tens of $Billions.

Simply click here and the name & trading symbol are yours.


Agios Pharmaceuticals Inc. (AGIO) full year performance was -36.61%

Price records that include history of low and high prices in the period of 52 weeks can tell a lot about the stock’s existing status and the future performance. Presently, Agios Pharmaceuticals Inc. shares are logging -41.55% during the 52-week period from high price, and 77.91% higher than the lowest price point for the same timeframe. The stock’s price range for the 52-week period managed to maintain the performance between $16.75 and $50.98.

The company’s shares, operating in the sector of Healthcare managed to top a trading volume set approximately around 579731 for the day, which was evidently lower, when compared to the average daily volumes of the shares.

When it comes to the year-to-date metrics, the Agios Pharmaceuticals Inc. (AGIO) recorded performance in the market was -9.34%, having the revenues showcasing 60.22% on a quarterly basis in comparison with the same period year before. At the time of this writing, the total market value of the company is set at 1.81B, as it employees total of 390 workers.

Specialists analysis on Agios Pharmaceuticals Inc. (AGIO)

During the last month, 0 analysts gave the Agios Pharmaceuticals Inc. a BUY rating, 0 of the polled analysts branded the stock as an OVERWEIGHT, 0 analysts were recommending to HOLD this stock, 0 of them gave the stock UNDERWEIGHT rating, and 0 of the polled analysts provided SELL rating.

According to the data provided on Barchart.com, the moving average of the company in the 100-day period was set at 23.99, with a change in the price was noted +6.82. In a similar fashion, Agios Pharmaceuticals Inc. posted a movement of +29.68% for the period of last 100 days, recording 765,578 in trading volumes.

Total Debt to Equity Ratio (D/E) can also provide valuable insight into the company’s financial health and market status. The debt to equity ratio can be calculated by dividing the present total liabilities of a company by shareholders’ equity. Debt to Equity thus makes a valuable metrics that describes the debt, company is using in order to support assets, correlating with the value of shareholders’ equity The total Debt to Equity ratio for AGIO is recording 0.00 at the time of this writing. In addition, long term Debt to Equity ratio is set at 0.00.

Trends and Technical analysis: Agios Pharmaceuticals Inc. (AGIO)

Raw Stochastic average of Agios Pharmaceuticals Inc. in the period of last 50 days is set at 67.65%. The result represents improvement in oppose to Raw Stochastic average for the period of the last 20 days, recording 50.84%. In the last 20 days, the company’s Stochastic %K was 67.39% and its Stochastic %D was recorded 71.78%.

Now, considering the stocks previous presentation, multiple moving trends are noted. Year-to-date Price performance of the company’s stock appears to be encouraging, given the fact the metric is recording -9.34%. Additionally, trading for the stock in the period of the last six months notably improved by 0.27%, alongside a downfall of -36.61% for the period of the last 12 months. The shares increased approximately by -10.91% in the 7-day charts and went down by 17.00% in the period of the last 30 days. Common stock shares were driven by 60.22% during last recorded quarter.

Leave a Comment

Your email address will not be published.

On Key

Related Posts